Authors
Latest:
Principles, Updates in Chemotherapy-Induced Nausea, VomitingChemotherapy-induced nausea and vomiting can impact patients’ treatment outcomes.
Latest:
Reconciling Medications in Mental Health Assessments Protects PatientsProcess helps prevent errors for individuals with chronic disorders who often have a higher risk of drug-drug interactions.
Latest:
Clinical Overview: Rivaroxaban (Xarelto) for Multiple Cardiovascular ConditionsRivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.
Latest:
Consequences of the Change Healthcare Cyberattack ContinueLegislative efforts regarding cybersecurity are ongoing, but individuals and organizations should remain vigilant.
Latest:
Continuous Glucose Monitoring Technology Continues to Rapidly ExpandSome devices are being sold OTC for individuals without diabetes to track their health.
Latest:
The Future of Pharmaceutical Care: Using Unique Patient Care Services to Drive Traffic and OutcomesFour examples of patient care services that pharmacies can implement and why they can be beneficial to a pharmacy’s business model.
Latest:
Medical Billing Is Now Part of Job DescriptionTechnicians with specialized skills in prescription billing can help pharmacists focus on clinical services.
Latest:
Oncology Overview: Sacituzumab Govitecan-hziy (Trodelvy) for Triple-Negative Breast CancerSacituzumab govitecan-hziy (Trodelvy) is indicated for the treatment of patients with triple-negative breast cancer who have received 2 prior therapies at minimum for metastatic disease.
Latest:
Management of Clostridoides Difficile: A Focus on the Pharmacist's Role in the Care ContinuumPatient education and counseling play a critical role in preventing C. difficile recurrence, and pharmacists are uniquely positioned to provide treatment recommendations, educate patients and health care providers, optimize transitions of care, and reduce the risk of recurrent CDI.
Latest:
Three Perspectives on Pharmacy Technician RetirementTechnicians can stay involved in the profession and connected with others after retirement
Latest:
Gabapentin Presents High Potential for MisuseAlthough the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.
Latest:
Pharmacists Can Help Children and Adolescents Manage MigrainesBe of value to patients and caregivers in forming a care plan for this challenging condition
Latest:
Tariffs, Tensions, and Transformation: Pharmacy at a CrossroadsJacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses how looming tariffs, vaccine misinformation, and rising drug costs are straining public health pharmacy efforts, while also sparking new opportunities for innovation, collaboration, and community-centered care amid uncertainty.
Latest:
Beating Brain Cancer With the Help of a Village and Giving BackPatient retraces her treatment journey from diagnosis through treatment for glioblastoma.
Latest:
Understand GLP-1/GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss TherapyPromising data have emerged suggesting a significant weight loss benefit for patients using GLP-1 agonists and GLP-1/GIP dual agonists.
Latest:
Improve Care for Patients With Community-Acquired PneumoniaEmpiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.
Latest:
Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs SyndromeTreatment for RLS includes lifestyle modifications, medication, and in some cases, non-drug therapies, aiming to reduce symptoms and improve sleep and daytime functioning.
Latest:
Preventing Drug Diversion in Pharmacy Settings: Best Practices, DEA Regulations, and Comprehensive Security StrategiesExpert provides a comprehensive overview of drug diversion prevention in pharmacy settings.
Latest:
Examining the 505(b)(2) Pathway and Implementation into EHRA panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.
Latest:
Improving the Patient-Pharmacist Relationship in Four Easy StepsPharmacists are the premier medication experts within health care, who understand more about medication interactions than most physicians and have the unique ability to prevent complications, improve adherence, and save lives.
Latest:
Metronidazole Twice Daily: A Pharmacokinetic and Clinical JustificationThis medication is associated with a number of adverse effects, such as gastrointestinal upset and peripheral neuropathies, that may be mitigated by less frequent dosing.
Latest:
Is PBM Reform Nearing the Finish Line?Legislative efforts in the states and Washington, DC, have made progress, but there is still a way to go.
Latest:
A Call to Pharmacists in the Delivery of Oncology CareThe expanded role of oncology pharmacists includes the opportunity to work in ambulatory settings, infusion centers, delivery of specialized in pharmacy services, evaluation of investigational new drugs, and manager roles in drug chain supply and in coordination of care.
Latest:
Expanded Use of Long-Acting Injectables for HIV and HIV PreventionAs HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.
Latest:
Insights on the UK's MHRA International Recognition ProcedureThe UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Latest:
Technology Can Help Navigate Financial Assistance Programs in Specialty CareThe goal of the financial counselor is to identify available funding for patient care in a timely manner, but the sheer number of resources and variables involved results in a long, tedious process.
Latest:
Advances in Sickle Cell Disease: New Gene Therapies and Management StrategiesTwo groundbreaking cell-based gene therapies, exagamglogene autotemcel and lovotibeglogene autotemcel, were recently approved by the FDA for the treatment of sickle cell disease.
